Initiative for MPT talk series recordings available
The Initiative for MPTs (IMPT) discussion series called "Let's Talk MPTs" is aimed at benefiting multipurpose prevention technologies (MPT) researchers and increasing interest in the MPTs among newer stakeholders. The series will cover an array of topics including socio-behavioral and market research, toxicity studies, policy and advocacy, and more.
Missed a previous discussion? Check out the recordings:
The Role of Cervicovaginal Microbiota on Contraceptive and MPT Development with Jacques Ravel, PhD, MSc (University of Maryland) and Jennifer Deese, PhD, MPH (RTI International)
Integrating Socio-behavioral & Market Research into MPT R&D with Betsy Tolley (FHI 360), Deborah Anderson (Boston University School of Medicine), Mary Weitzel (Yaso Therapeutics), Matthew Quaife (London School of Hygiene & Tropical Medicine), Khatija Ahmed (Setshaba Research Centre), and Joseph Murungu (Pangaea Zimbabwe AIDS Trust)
Toxicity Study Considerations for MPT and HIV Prevention R&D with Tom Moench (Mucommune) and Miles ( ZabBio)
Combining Active Pharmaceutical Ingredients (APIs): MPT Development & Regulatory Considerations with Deven Shah (Certara), Kevin Hershberger (Certara), and Tamra Goodrow (Deer Run Regulatory Consulting)
On Wednesday June 30 at 10:30 AM EST this series will continue with a discussion about Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches. Featured discussants include Rahima Benhabbour, PhD (University of North Carolina Chapel Hill), Courtney Jarrahian, MS (PATH) and Joseph Romano, PhD (NWJ Group). Register here for the event.